%0 Journal Article %J Am J Med Genet A %D 2014 %T Next generation sequencing in nonsyndromic intellectual disability: from a negative molecular karyotype to a possible causative mutation detection. %A Athanasakis, Emmanouil %A Licastro, Danilo %A Faletra, Flavio %A Fabretto, Antonella %A Dipresa, Savina %A Vozzi, Diego %A Morgan, Anna %A d'Adamo, Adamo P %A Pecile, Vanna %A Biarnés, Xevi %A Gasparini, Paolo %K Computational Biology %K Exome %K Female %K Genes, Recessive %K Genes, X-Linked %K Genome-Wide Association Study %K High-Throughput Nucleotide Sequencing %K Humans %K Intellectual Disability %K Karyotype %K Male %K Mutation %K Workflow %X

The identification of causes underlying intellectual disability (ID) is one of the most demanding challenges for clinical Geneticists and Researchers. Despite molecular diagnostics improvements, the vast majority of patients still remain without genetic diagnosis. Here, we report the results obtained using Whole Exome and Target Sequencing on nine patients affected by isolated ID without pathological copy number variations, which were accurately selected from an initial cohort of 236 patients. Three patterns of inheritance were used to search for: (1) de novo, (2) X-linked, and (3) autosomal recessive variants. In three of the nine proband-parent trios analyzed, we identified and validated two de novo and one X-linked potentially causative mutations located in three ID-related genes. We proposed three genes as ID candidate, carrying one de novo and three X-linked mutations. Overall, this systematic proband-parent trio approach using next generation sequencing could explain a consistent percentage of patients with isolated ID, thus increasing our knowledge on the molecular bases of this disease and opening new perspectives for a better diagnosis, counseling, and treatment.

%B Am J Med Genet A %V 164A %P 170-6 %8 2014 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24307393?dopt=Abstract %R 10.1002/ajmg.a.36274 %0 Journal Article %J PLoS One %D 2010 %T Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor. %A Biarnés, Xevi %A Marchiori, Alessandro %A Giorgetti, Alejandro %A Lanzara, Carmela %A Gasparini, Paolo %A Carloni, Paolo %A Born, Stephan %A Brockhoff, Anne %A Behrens, Maik %A Meyerhof, Wolfgang %K Amino Acid Sequence %K Calcium %K Cell Line %K Computational Biology %K Dose-Response Relationship, Drug %K Humans %K Intracellular Space %K Ligands %K Models, Molecular %K Molecular Sequence Data %K Mutagenesis, Site-Directed %K Phenylthiourea %K Protein Binding %K Protein Structure, Secondary %K Receptors, G-Protein-Coupled %X

Humans' bitter taste perception is mediated by the hTAS2R subfamily of the G protein-coupled membrane receptors (GPCRs). Structural information on these receptors is currently limited. Here we identify residues involved in the binding of phenylthiocarbamide (PTC) and in receptor activation in one of the most widely studied hTAS2Rs (hTAS2R38) by means of structural bioinformatics and molecular docking. The predictions are validated by site-directed mutagenesis experiments that involve specific residues located in the putative binding site and trans-membrane (TM) helices 6 and 7 putatively involved in receptor activation. Based on our measurements, we suggest that (i) residue N103 participates actively in PTC binding, in line with previous computational studies. (ii) W99, M100 and S259 contribute to define the size and shape of the binding cavity. (iii) W99 and M100, along with F255 and V296, play a key role for receptor activation, providing insights on bitter taste receptor activation not emerging from the previously reported computational models.

%B PLoS One %V 5 %P e12394 %8 2010 %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/20811630?dopt=Abstract %R 10.1371/journal.pone.0012394